» Articles » PMID: 34133005

Viral Load and Disease Severity in COVID-19

Abstract

The relationship between COVID-19 severity and viral load is unknown. Our objective was to assess the association between viral load and disease severity in COVID-19. In this single center observational study of adults with laboratory confirmed SARS-CoV-2, the first positive in-hospital nasopharyngeal swab was used to calculate the log10 copies/ml [log10 copy number (CN)] of SARS-CoV-2. Four categories based on level of care and modified sequential organ failure assessment score (mSOFA) at time of swab were determined. Median log10CN was compared between different levels of care and mSOFA quartiles. Median log10CN was compared in patients who did and did not receive influenza vaccine, and the correlation between log10CN and D-dimer was examined. We found that of 396 patients, 54.3% were male, and 25% had no major comorbidity. Hospital mortality was 15.7%. Median mSOFA was 2 (IQR 0-3). Median log10CN was 5.5 (IQR 3.3-8.0). Median log10CN was highest in non-intubated ICU patients [6.4 (IQR 4.4-8.1)] and lowest in intubated ICU patients [3.6 (IQR 2.6-6.9)] (p value < 0.01). In adjusted analyses, this difference remained significant [mean difference 1.16 (95% CI 0.18-2.14)]. There was no significant difference in log10CN between other groups in the remaining pairwise comparisons. There was no association between median log10CN and mSOFA in either unadjusted or adjusted analyses or between median log10CN in patients with and without influenza immunization. There was no correlation between log10CN and D-dimer. We conclude, in our cohort, we did not find a clear association between viral load and disease severity in COVID-19 patients. Though viral load was higher in non-intubated ICU patients than in intubated ICU patients there were no other significant differences in viral load by disease severity.

Citing Articles

Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.

Gazeau S, Deng X, Brunet-Ratnasingham E, Kaufmann D, Larochelle C, Morel P bioRxiv. 2024; .

PMID: 39131351 PMC: 11312602. DOI: 10.1101/2024.08.01.605860.


Investigation of Initial Viral Loads and Patient Characteristics as Predictors of COVID-19 Outcomes: A Retrospective Cohort Study.

Yusri E, Putra S, Mahata L, Putra A Infect Dis Rep. 2023; 15(5):589-599.

PMID: 37888138 PMC: 10606841. DOI: 10.3390/idr15050057.


Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.

Klussmann J, Grosheva M, Meiser P, Lehmann C, Nagy E, Szijarto V Sci Rep. 2023; 13(1):6839.

PMID: 37100830 PMC: 10132439. DOI: 10.1038/s41598-023-32546-z.


Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatment.

Lee V, Chan S, Tam Y, Chau T, Chan J, Chan S Int J Infect Dis. 2023; 132:40-49.

PMID: 37072051 PMC: 10105908. DOI: 10.1016/j.ijid.2023.04.397.


Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients.

Lai M, Wang K, Ding C, Yin Y, Lin X, Xu C Ann Clin Microbiol Antimicrob. 2023; 22(1):22.

PMID: 36944961 PMC: 10029781. DOI: 10.1186/s12941-023-00569-z.


References
1.
Wang P, Anderson N, Pan Y, Poon L, Charlton C, Zelyas N . The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception. Clin Chem. 2020; . PMC: 7108508. DOI: 10.1093/clinchem/hvaa080. View

2.
Yu F, Yan L, Wang N, Yang S, Wang L, Tang Y . Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients. Clin Infect Dis. 2020; 71(15):793-798. PMC: 7184442. DOI: 10.1093/cid/ciaa345. View

3.
Zacharioudakis I, Prasad P, Zervou F, Basu A, Inglima K, Weisenberg S . Association of SARS-CoV-2 Genomic Load with Outcomes in Patients with COVID-19. Ann Am Thorac Soc. 2020; 18(5):900-903. PMC: 8086542. DOI: 10.1513/AnnalsATS.202008-931RL. View

4.
Salem M, El-Hennawy D . The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19. Med Hypotheses. 2020; 140:109752. PMC: 7194943. DOI: 10.1016/j.mehy.2020.109752. View

5.
Donnino M, Moskowitz A, Thompson G, Heydrick S, Pawar R, Berg K . Comparison between Patients Hospitalized with Influenza and COVID-19 at a Tertiary Care Center. J Gen Intern Med. 2021; 36(6):1689-1695. PMC: 7971402. DOI: 10.1007/s11606-021-06647-2. View